In this paper we investigated lipid and metabolite changes in diabetic neuropathy, using untargeted lipidomics and metabolomics analyses of the spinal cords from streptozotocin-treated diabetic rats.170 metabolites and 45 lipids were dysregulated in the painful diabetic neuropathy (PDN) phase. Pathway enrichment analysis revealed perturbations in starch and sucrose, tryptophan, pyrimidine, cysteine and methionine, thiamine, tyrosine, and nucleotides. The disturbance of tyrosine, tryptophan, methionine, triacylglycerol, and phosphatidylethanolamine metabolism indicated that pathological mechanisms in the PDN involved energy metabolism, oxidative stress, and neural reparative regeneration. These revelations offered potential biomarkers for PDN and enriched the comprehension of the complex molecular mechanisms characterizing PDN, establishing a solid foundation for subsequent inquiries into neural convalescence and recovery after PDN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349861PMC
http://dx.doi.org/10.1007/s11011-024-01376-xDOI Listing

Publication Analysis

Top Keywords

diabetic neuropathy
8
pdn
5
metabolomic lipidomic
4
lipidomic profiling
4
profiling spinal
4
spinal cord
4
cord type
4
type diabetes
4
diabetes mellitus
4
mellitus rats
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!